# NHS England

Type: organization

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/nhs-england
Canonical HTML page: https://getbiobrief.com/entity/nhs-england

## Timeline

- **2026-02-20**: MHRA Intervention — The UK medicines regulator issues a formal pause on the trial due to newly identified concerns.
- **2025-01-15**: Clinical Trial Launch — NHS England begins the formal clinical trial to gather data on the effects of puberty blockers.
- **2024-04-10**: Cass Review Published — Final report recommends that puberty blockers only be administered within a research framework.

## Recent coverage (1 stories)

### MHRA Halts UK Puberty Blocker Clinical Trial Amid Safety Concerns
2026-02-20 23:05:18 · Sentiment: Negative · Impact: 7/10 · Sources: 9

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has suspended a pivotal clinical trial investigating the use of puberty blockers for children. The pause follows the emergence of new regulatory concerns, effectively halting the primary research pathway for gender-affirming care in the UK.
Full story: https://getbiobrief.com/story/mhra-pauses-uk-puberty-blocker-trial

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.